PPARA and metabolic dysfunction-associated steatohepatitis: In this study, in order to further understand the mechanism of the PPAR α/δ agonist on NASH, the pharmacodynamics and transcriptome regulation of GFT505 were evaluated in CDAHFD fed mouse NASH model.